Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile–Associated Diarrhea: A Phase 2a Multicenter Clinical Trial | Zendy

Molly O’Gorman | Zendy; Marian G. Michaels | Zendy; Sheldon L. Kaplan | Zendy; Anthony Otley | Zendy; Larry K. Kociolek | Zendy; Edward J. Hoffenberg | Zendy; Kwang Sik Kim | Zendy; Sharon Nachman | Zendy; Marian D. Pfefferkorn | Zendy; Timothy Sentongo | Zendy; Janice E. Sullivan | Zendy; P.S. Sears | Zendy

Open Access

Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile–Associated Diarrhea: A Phase 2a Multicenter Clinical Trial

Author(s) -

Molly O’Gorman,

Marian G. Michaels,

Sheldon L. Kaplan,

Anthony Otley,

Larry K. Kociolek,

Edward J. Hoffenberg,

Kwang Sik Kim,

Sharon Nachman,

Marian D. Pfefferkorn,

Timothy Sentongo,

Janice E. Sullivan,

P.S. Sears

Publication year - 2017

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pix037

Subject(s) - medicine , fidaxomicin , diarrhea , clostridium difficile , pharmacokinetics , multicenter study , antibiotic associated diarrhea , clinical trial , gastroenterology , intensive care medicine , vancomycin , microbiology and biotechnology , antibiotics , randomized controlled trial , staphylococcus aureus , biology , bacteria , genetics

Fidaxomicin is an approved therapy for Clostridium difficile-associated diarrhea (CDAD) in adults. The safety of fidaxomicin in children has not been reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research